266 related articles for article (PubMed ID: 11102278)
1. From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes.
Lee JH; Klein HG
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):585-600. PubMed ID: 11102278
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte reduction of cellular blood components. Effectiveness, benefits, quality control, and costs.
Lane TA
Arch Pathol Lab Med; 1994 Apr; 118(4):392-404. PubMed ID: 8166589
[TBL] [Abstract][Full Text] [Related]
3. Advances in transfusion therapy.
Beck SJ
Clin Lab Sci; 1994; 7(4):225-31. PubMed ID: 10147432
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte-reduced blood components in transfusion medicine. Current indications and prospects for the future.
Klapper EB; Goldfinger D
Clin Lab Med; 1992 Dec; 12(4):711-21. PubMed ID: 1286560
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of transfusions caused by leukocytes.
Raife TJ
J Intraven Nurs; 1997; 20(5):238-44. PubMed ID: 9369624
[TBL] [Abstract][Full Text] [Related]
6. [Immunological effects of erythrocyte and leukocyte transfusion. Work Group Blood Group Serology of the Medical Advisory Commission of the College for Blood Transfusion of the Netherlands Red Cross].
Brand A; van Rhenen DJ
Ned Tijdschr Geneeskd; 1997 Jan; 141(3):136-40. PubMed ID: 9053759
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte depletion of cellular blood components.
Lane TA
Curr Opin Hematol; 1994 Nov; 1(6):443-51. PubMed ID: 9371321
[TBL] [Abstract][Full Text] [Related]
8. The use of leukocyte-reduced blood components.
Miller JP; Mintz PD
Hematol Oncol Clin North Am; 1995 Feb; 9(1):69-90. PubMed ID: 7737945
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion.
Porter D; Levine JE
Semin Hematol; 2006 Jan; 43(1):53-61. PubMed ID: 16412789
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect.
Díez-Martín JL; Gómez-Pineda A; Serrano D; Carrión R; Balsalobre P; Buño I
Bone Marrow Transplant; 2004 May; 33(10):1037-41. PubMed ID: 15064692
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte depletion for safe blood transfusion.
Singh S; Kumar A
Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
[TBL] [Abstract][Full Text] [Related]
13. Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease.
Corash L; Lin L
Bone Marrow Transplant; 2004 Jan; 33(1):1-7. PubMed ID: 14647263
[TBL] [Abstract][Full Text] [Related]
14. From whole blood to component therapy: the economic, supply/demand need for implementation of component therapy in sub-Saharan Africa.
Erhabor O; Adias TC
Transfus Clin Biol; 2011 Dec; 18(5-6):516-26. PubMed ID: 22037104
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of transfusion-associated immunosuppression.
Blajchman MA; Bordin JO
Curr Opin Hematol; 1994 Nov; 1(6):457-61. PubMed ID: 9371323
[TBL] [Abstract][Full Text] [Related]
16. [Towards the use of intravenous apoptotic leukocyte infusion as a cell-based therapy approach?].
Saas P; Bonnefoy F; Kleinclauss F; Sun Y; Tiberghien P; Gaugler B; Perruche S
Transfus Clin Biol; 2008 Jun; 15(3):98-108. PubMed ID: 18524660
[TBL] [Abstract][Full Text] [Related]
17. Fatal graft-versus-host disease after a small leukocyte transfusion in a patient with lymphoma and varicella.
Betzhold J; Hong R
Pediatrics; 1978 Jul; 62(1):63-6. PubMed ID: 28510
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of recipient leukocyte infusion as antitumor therapy following nonmyeloablative allogeneic hematopoietic cell transplantation.
Saito TI; Rubio MT; Sykes M
Exp Hematol; 2006 Sep; 34(9):1271-7. PubMed ID: 16939820
[TBL] [Abstract][Full Text] [Related]
19. [Biological effects of allogenic leukocytes and leukocyte-depleted blood cell products].
Vásová I; Mayer J
Vnitr Lek; 1995 Oct; 41(10):713-8. PubMed ID: 8578706
[TBL] [Abstract][Full Text] [Related]
20. Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation.
Teshima T; Liu C; Lowler KP; Dranoff G; Ferrara JL
Cancer Res; 2002 Feb; 62(3):796-800. PubMed ID: 11830535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
